News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
A federal judge says that recent layoffs at the U.S. Department of Health and Human Services were likely unlawful and must be ...
Synthetic products posing as kratom mislead and endanger consumers; AKA urges FDA to take decisive action against violative ...
A federal judge has ruled that recent mass layoffs at the US Department of Health and Human Services were likely unlawful and ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
2h
Grist on MSNHow to access food before, during, and after a disasterHaving enough food and water on hand when a disaster strikes is critical, but it’s not all there is to preparing for an emergency. It’s important to know where to go for free fresh or hot food, clean ...
As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...
Americans are increasingly demanding that chemicals and toxic food dyes be removed from items they consume, clean with, wear, ...
The elimination of 3,500 full-time employees at the FDA risks undermining the very innovation and domestic capacity the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results